The S&P/TSX Surges, the Loonie Plunges, and is This Company the Next Amgen?

Equities finally catch a bid in 2014.

| More on:
The Motley Fool

Canadian equities surged higher on Tuesday boosted by surging commodity prices and a weak Canadian dollar.

The S&P/TSX Composite Index (^OSPTX) ended the trading session up 101.40 points, or 0.75%, to 13,596. U.S. equities also rallied sharply higher with the broad based Dow Jones Industrials Average rallying 105.84 points, or 0.64%.

Energy issues led the S&P/TSX 60 higher. Canada’s largest energy companies Suncor (TSX:SU, NYSE:SU) and Imperial Oil (TSX:IMO) each finished the trading session higher by 1.61% and 1.30% respectively.

And cold weather in the United States put a big bid underneath natural gas prices. On the New York Mercantile Exchange, natural gas futures for delivery in February traded at US$4.374 per million British thermal units during U.S. trading, up 1.57%. Gas weighted names like Encana (TSX:ECA, NYSE:ECA) and Talisman (TSX:TLM, NYSE:TLM) each finished up 0.64% and 2.38% respectively.

One piece of economic news that sent shares higher was Monday’s U.S. Senate confirmation of Janet Yellen as the next Federal Reserve chair. Yellen is an advocate of a more dovish monetary policy arguing that the central bank should do more to stimulate the country’s economic recovery. Such a policy would likely be bullish for equity prices.

Meanwhile, the Canadian dollar fell sharply on weak economic day down 1.10% to US$1.0773 – a three year low.

This way likely due to the nation’s merchandise trade deficit which widened to $940 million in November – nine times what economists had forecasted according to Bloomberg. The report is fueling doubt that the pickup in exports promised by the Bank of Canada will drive economic growth.

The Loonie extended losses later in the day after the Ivey’s Purchasing Manager’s Index fell to 46.3 in December, versus a reading of 53.7 in November. The index is based on a 100 point scale where a reading below 50 indicates a contraction in activity.

Here at Fool HQ, we’re not stressing about this type of macroeconomic volatility. While wild currency swings certainly affect our accounts day-to-day, over the long run these will roughly even out.

But today’s numbers do have some important takeaways. First, slow economic growth should kick a Bank of Canada rate hike down the road another six months or more. Second, investors with a home-bias in their portfolios are missing a big opportunity in the faster growing United States.

On the corporate side, shares of Valeant Pharmaceuticals (TSX:VRX, NYSE:VRX) surged 12.53% after the company announced that it’s looking to join the top five pharma companies in the world by market capitalization by 2016. During a conference call with analysts, Chief Executive Michael Pearson also predicted that the company’s revenue and cash earnings would increased 40% in 2014.

Valeant has earned the reputation of Canada’s ‘Little Johnson & Johnson’ after its remarkable run this past few years. The company’s winning formula has been to buy up small biotech firms and creating value by pushing these promising new drugs through its large distribution network.

This has been a great recipe for shareholders. Valeant shares have rallied 120% in the past year. And after this report, investors can likely expect those gains to continue in the New Year.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Disclosure: Robert Baillieul has no positions in any of the stocks mentioned in this article.  

More on Investing

man touches brain to show a good idea
Dividend Stocks

Investors: How to Maximize Returns and Minimize Risk in Today’s Market

Forget about getting rich quick. Take less risk in the stock market by investing in diversified ETFs and loading up…

Read more »

investment research
Bank Stocks

Is This Canadian Bank Down 8.5% Too Good to Pass Up?

This Canadian bank now offers a 6% dividend yield.

Read more »

bulb idea thinking
Dividend Stocks

I’d Consider These 5 Stocks for a $10,000 Canadian Dividend Portfolio

Here are the five top Canadian dividend stocks I think should be in every long-term investor's portfolio in this period…

Read more »

Start line on the highway
Metals and Mining Stocks

The Smartest Canadian Stock to Buy With Only $300 Right Now

This copper Canadian stock is due for even more growth, making now a great time to pick it up.

Read more »

3 colorful arrows racing straight up on a black background.
Investing

1 Must-Consider Stock as the TSX Reaches New Heights

Constellation Software (TSX:CSU) stock still looks like a great deal at around $5,000 per share.

Read more »

Canada national flag waving in wind on clear day
Investing

3 Must-Have Canadian Stocks for Your TFSA During Economic Uncertainty

These three all-weather Canadian stocks are ideal additions to your TFSA.

Read more »

stock research, analyze data
Dividend Stocks

The Smartest Dividend Knight to Buy With $800 Right Now

One of the TSX’s dividend knights is a smart buy today, even with a less than $1,000 investment.

Read more »

A close up color image of a small green plant sprouting out of a pile of Canadian dollar coins "loonies."
Investing

1 Magnificent TSX Stock Down 80% With Massive Growth Potential

Down 80% from all-time highs, this top TSX stock trades at a sizeable discount given the company's steady growth estimates.

Read more »